Akin Gump Wins Federal Circuit Decision in Janssen Pharmaceutica Case
Contact:
(Washington, D.C.) – The U.S. Court of Appeals for the Federal Circuit has ruled in favor of Akin Gump client Janssen Pharmaceutica in a case against Mylan Laboratories involving a patent pertaining to Janssen’s schizophrenia drug.
To view the ruling, please click here.
The Akin Gump team representing Janssen comprised Supreme Court and appellate practice head Pratik Shah and partner Julius Chen, and intellectual property partner Rubén Muñoz.
Founded in 1945, Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
# # #
People Mentioned in This News
© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.